このエピソードについて

英語
アメリカ合衆国

文字起こし 🔗

過去のエピソードを検索

NeuroFrontiersの以前のエピソードを検索します。

このポッドキャストの他のエピソード

Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC Cxplore how cell-based therapies are reshaping treatment strategies for multiple sclerosis (MS). Hear from Dr. Mark Freedman as he examines the scientific rationale behind emerging strategies. Dr. Freedman is a Profes…
Guest: Henry Kaminski, MD Myasthenia gravis is an unpredictable condition, with symptoms and treatment responses that can vary widely from one patient to the next. Tune in to hear Dr. Henry Kaminski explain how to navigate this variability and make thoughtful, individualized treatment de…
Host: Brian P. McDonough, MD, FAAFP Guest: Austin Larson, MD Emerging research on thymidine kinase 2 deficiency (TK2d) provides new insights into its global genetic prevalence and variability across genetic ancestries. By combining clinical literature with large genomic databases, in…
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC The role of cell-based therapies in multiple sclerosis (MS) is evolving, with immune system replacement via autologous stem cells, investigational mesenchymal repair strategies, and CAR T-cell approaches changing the treatment …
免責: このページに埋め込まれているポッドキャストとアートワークは ReachMD からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。